ANSELL LIMITED (ANN)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

ANN - ANSELL LIMITED

FNArena Sector : Commercial Services & Supplies
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 3.14
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

Ansell is an Australian manufacturer of protective industrial equipment and household and medical gloves. It is the remnant of Pacific Dunlop, once a mighty conglomerate that listed in 1985. The name was changed to Ansell in 2002.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$34.18

17 Jan
2025

-0.140

OPEN

$34.38

-0.41%

HIGH

$34.41

244,240

LOW

$34.01

TARGET
$29.85 -12.7% downside
OTHER COMPANIES IN THE SAME SECTOR
AIM . ASB . CUP . DGL . KPG . QHL . RDX . SRV .
FNARENA'S MARKET CONSENSUS FORECASTS
ANN: 1
Title FY25
Forecast		 FY26
Forecast
EPS (cps) 177.0 xxx
DPS (cps) 76.6 xxx
EPS Growth N/A xxx
DPS Growth N/A xxx
PE Ratio 19.4 xxx
Dividend Yield 2.2% xxx
Div Pay Ratio(%) 43.3% xxx
This company reports in USD.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: 1.05%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 1.03

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 26/08 - (franking ex-di

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic 115.4181.7257.6172.6174.690.7
DPS All 67.471.0160.878.969.557.5
Sales/Revenue 2,096.1 M2,407.2 M2,717.2 M2,691.8 M2,460.6 M2,471.1 M
Book Value Per Share 1,506.71,573.01,622.41,782.71,908.51,944.1
Net Operating Cash Flow 247.2 M409.5 M207.0 M278.8 M243.5 M388.4 M
Net Profit Margin 7.45 %9.83 %12.17 %8.13 %8.96 %4.72 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed 7.68 %11.80 %16.18 %10.16 %9.49 %4.45 %
Return on Invested Capital 5.61 %8.61 %12.06 %7.75 %7.48 %3.35 %
Return on Assets 4.59 %6.82 %9.18 %6.00 %5.92 %2.70 %
Return on Equity 7.68 %11.80 %16.18 %10.16 %9.49 %4.45 %
Return on Total Capital 9.82 %11.50 %16.22 %11.84 %9.66 %8.15 %
Free Cash Flow ex dividends 102.8 M221.5 M-7.0 M66.1 M50.1 M211.4 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt 29 M99 M28 M26 M176 M116 M
Long Term Debt 749 M740 M659 M680 M566 M1,167 M
Total Debt 777 M839 M687 M706 M743 M1,284 M
Goodwill - Gross 1,407 M1,416 M1,321 M1,416 M1,481 M1,471 M
Cash & Equivalents - Generic 566 M594 M320 M300 M239 M1,366 M
Price To Book Value 1.782.332.681.251.401.37

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex 61.0 M96.7 M110.9 M93.1 M99.9 M95.8 M
Capex % of Sales 2.91 %4.02 %4.08 %3.46 %4.06 %3.88 %
Cost of Goods Sold 1,289 M1,501 M1,642 M1,783 M1,551 M1,524 M
Selling, General & Admin. Exp & Other 531 M580 M617 M570 M613 M649 M
Research & Development 17 M21 M19 M24 M27 M25 M
Investments - Total 4 M20 M31 M29 M18 M17 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.3

No. Of Recommendations

4
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

21/08/2024

3

Neutral

$32.50

-4.92%

FY24 results from Ansell were in line with the midpoint of guidance although better than Citi had anticipated, given a one-off pricing benefit as well as lower operating expenditure. Guidance for adjusted FY25 EPS of US107-127c is ahead of expectations.

The broker points out the wide range in guidance is indicative of the uncertainty being faced at the macro level amid the integration of the KBU acquisition. This keeps the rating at Neutral. Target is raised to $32.50 from $27.25.

FORECAST
Citi forecasts a full year FY25 dividend of 71.50 cents and EPS of 175.11 cents.
Citi forecasts a full year FY26 dividend of 79.11 cents and EPS of 197.32 cents.

Ord Minnett

xx/xx/xxxx

3

xxxxxxx xx xxxx xxxx xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

0

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
Access Extra Coverage Research History >

ANN STOCK CHART

FNArena News on ANN

1
Rudi’s View: A Rally With No Earnings Support

Nov 14 2024 - Rudi's View
2
Rudi’s View: Preparing For The Trump Years

Nov 13 2024 - Rudi's View
3
Rudi’s View: Trump Returns, What Now?

Nov 07 2024 - Rudi's View
4
Treasure Chest: Ansell

Oct 31 2024 - Treasure Chest
5
August Result Season 2024: The Wrap

Sep 24 2024 - Feature Stories

Latest Commercial Services & Supplies News

1
Looking For Durable, Needle-Moving Growth In AI

Jan 13 2025 - International
2
In Brief: Dicker Data, Light & Wonder, Codan

Dec 20 2024 - Weekly Reports
3
Pro Medicus, A Global Software Super Star

Dec 19 2024 - Australia
4
Alliance Aviation Cleared For Dividend Takeoff

Dec 16 2024 - Small Caps
5
The 2024 Gen.Ai Xmas Special, Incl 2025 Outlook

Dec 12 2024 - Australia
6
Dicker Data’s Pick And Shovel AI Strategy 

Dec 03 2024 - Small Caps
7
Higher Margins Underpin Gentrack’s Ambitions

Nov 28 2024 - Small Caps
8
Targets Jump For Embattled WiseTech

Nov 28 2024 - Australia
9
Rising Margins Boost ALS’ Favourable Outlook

Nov 22 2024 - Australia
10
EVs And Capital Management Drive FleetPartners

Nov 20 2024 - Small Caps